- $28.86m
- $864.68m
- $945.95m
Annual income statement for 2U, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 575 | 775 | 946 | 963 | 946 |
| Cost of Revenue | |||||
| Gross Profit | 297 | 385 | 497 | 495 | 512 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 821 | 965 | 1,114 | 1,221 | 1,188 |
| Operating Profit | -247 | -191 | -169 | -258 | -243 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -255 | -218 | -196 | -323 | -316 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -235 | -216 | -195 | -322 | -318 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -235 | -216 | -195 | -322 | -318 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -235 | -216 | -195 | -322 | -318 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.88 | -3.27 | -2.36 | -2.7 | -1.85 |